Intravitreal bevacizumab in myopic neovascular membranes: 24-month results

Ophthalmology

Volumn 120, Issue 7, 2013, Pages

  Ruiz Moreno, Jose M ^a   López Gálvez, María I ^b   Montero Moreno, Javier A ^c   Pastor Jimeno, Jose C ^b  

^a Regional Development Institute of the Castilla   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MYOPIA; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA FOVEA; RETINAL THICKNESS; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 84879755274     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.03.006     Document Type: Letter

References (5)

1. J.M. Ruiz-Moreno, J.A. Montero, L. Arias et al. Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization Retina 30 2010 1609 1615
2. P. Iacono, M.B. Parodi, A. Papayannis et al. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series Retina 31 2011 1841 1847
3. H. Nakanishi, A. Tsujikawa, Y. Yodoi et al. Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization Eye (Lond) 25 2011 375 381
4. J.P. Tong, W.M. Chan, D.T. Liu et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization Am J Ophthalmol 141 2006 456 462
5. J.M. Ruiz-Moreno, J.A. Montero, L. Arias et al. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization Acta Ophthalmol 90 2012 e82 e83